247 related articles for article (PubMed ID: 22243995)
21. Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis.
Ogino S; Kawasaki T; Brahmandam M; Cantor M; Kirkner GJ; Spiegelman D; Makrigiorgos GM; Weisenberger DJ; Laird PW; Loda M; Fuchs CS
J Mol Diagn; 2006 May; 8(2):209-17. PubMed ID: 16645207
[TBL] [Abstract][Full Text] [Related]
22. MethylMeter(®): bisulfite-free quantitative and sensitive DNA methylation profiling and mutation detection in FFPE samples.
McCarthy D; Pulverer W; Weinhaeusel A; Diago OR; Hogan DJ; Ostertag D; Hanna MM
Epigenomics; 2016 Jun; 8(6):747-65. PubMed ID: 27337298
[TBL] [Abstract][Full Text] [Related]
23. Pyrosequencing assay to measure LINE-1 methylation level in esophageal squamous cell carcinoma.
Iwagami S; Baba Y; Watanabe M; Shigaki H; Miyake K; Ida S; Nagai Y; Ishimoto T; Iwatsuki M; Sakamoto Y; Miyamoto Y; Baba H
Ann Surg Oncol; 2012 Aug; 19(8):2726-32. PubMed ID: 22187122
[TBL] [Abstract][Full Text] [Related]
24. Expression and promoter methylation status of hMLH1, MGMT, APC, and CDH1 genes in patients with colon adenocarcinoma.
Michailidi C; Theocharis S; Tsourouflis G; Pletsa V; Kouraklis G; Patsouris E; Papavassiliou AG; Troungos C
Exp Biol Med (Maywood); 2015 Dec; 240(12):1599-605. PubMed ID: 25908636
[TBL] [Abstract][Full Text] [Related]
25. Droplet digital PCR (ddPCR) using FFPE DNA to assess methylation status of
Abarna R; J R; Chacko G; Pai R
J Clin Pathol; 2023 Dec; 76(12):860-864. PubMed ID: 37709490
[No Abstract] [Full Text] [Related]
26. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC.
Scarpa M; Scarpa M; Castagliuolo I; Erroi F; Kotsafti A; Basato S; Brun P; D'Incà R; Rugge M; Angriman I; Castoro C
Oncotarget; 2016 Mar; 7(9):10322-31. PubMed ID: 26862732
[TBL] [Abstract][Full Text] [Related]
27. Methylation of the polycomb group target genes is a possible biomarker for favorable prognosis in colorectal cancer.
Dallol A; Al-Maghrabi J; Buhmeida A; Gari MA; Chaudhary AG; Schulten HJ; Abuzenadah AM; Al-Ahwal MS; Sibiany A; Al-Qahtani MH
Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2069-75. PubMed ID: 23010642
[TBL] [Abstract][Full Text] [Related]
28. MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers.
Shima K; Morikawa T; Baba Y; Nosho K; Suzuki M; Yamauchi M; Hayashi M; Giovannucci E; Fuchs CS; Ogino S
Cancer Causes Control; 2011 Feb; 22(2):301-9. PubMed ID: 21140203
[TBL] [Abstract][Full Text] [Related]
29. O6-Methyguanine-DNA Methyl Transferase (MGMT) Promoter Methylation in Serum DNA of Iranian Patients with Colorectal Cancer.
Alizadeh Naini M; Kavousipour S; Hasanzarini M; Nasrollah A; Monabati A; Mokarram P
Asian Pac J Cancer Prev; 2018 May; 19(5):1223-1227. PubMed ID: 29801405
[TBL] [Abstract][Full Text] [Related]
30. Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer.
de Vogel S; Wouters KA; Gottschalk RW; van Schooten FJ; de Goeij AF; de Bruïne AP; Goldbohm RA; van den Brandt PA; Weijenberg MP; van Engeland M
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3086-96. PubMed ID: 19843671
[TBL] [Abstract][Full Text] [Related]
31. DNA Methylation by Bisulfite Next-Generation Sequencing for MLH1 and MGMT in Oral Squamous Cell Carcinomas and Potentially Malignant Disorders: An Integrative Analysis towards Field Cancerization.
Padin-Iruegas E; Chamorro-Petronacci CM; Sines-Cajade I; Lorenzo-Pouso AI; Blanco-Carrión A; Pérez-Jardón A; Gándara-Vila P; Pérez-Sayans M
Medicina (Kaunas); 2022 Jun; 58(7):. PubMed ID: 35888599
[No Abstract] [Full Text] [Related]
32. MGMT-STP27 methylation status as predictive marker for response to PCV in anaplastic Oligodendrogliomas and Oligoastrocytomas. A report from EORTC study 26951.
van den Bent MJ; Erdem-Eraslan L; Idbaih A; de Rooi J; Eilers PH; Spliet WG; den Dunnen WF; Tijssen C; Wesseling P; Sillevis Smitt PA; Kros JM; Gorlia T; French PJ
Clin Cancer Res; 2013 Oct; 19(19):5513-22. PubMed ID: 23948976
[TBL] [Abstract][Full Text] [Related]
33. The global DNA methylation surrogate LINE-1 methylation is correlated with MGMT promoter methylation and is a better prognostic factor for glioma.
Ohka F; Natsume A; Motomura K; Kishida Y; Kondo Y; Abe T; Nakasu Y; Namba H; Wakai K; Fukui T; Momota H; Iwami K; Kinjo S; Ito M; Fujii M; Wakabayashi T
PLoS One; 2011; 6(8):e23332. PubMed ID: 21829728
[TBL] [Abstract][Full Text] [Related]
34. The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas.
Furlan D; Carnevali I; Marcomini B; Cerutti R; Dainese E; Capella C; Riva C
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3329-36. PubMed ID: 16740754
[TBL] [Abstract][Full Text] [Related]
35. MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma.
Rivera AL; Pelloski CE; Gilbert MR; Colman H; De La Cruz C; Sulman EP; Bekele BN; Aldape KD
Neuro Oncol; 2010 Feb; 12(2):116-21. PubMed ID: 20150378
[TBL] [Abstract][Full Text] [Related]
36. MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status.
Bady P; Sciuscio D; Diserens AC; Bloch J; van den Bent MJ; Marosi C; Dietrich PY; Weller M; Mariani L; Heppner FL; Mcdonald DR; Lacombe D; Stupp R; Delorenzi M; Hegi ME
Acta Neuropathol; 2012 Oct; 124(4):547-60. PubMed ID: 22810491
[TBL] [Abstract][Full Text] [Related]
37. Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism and folate intake in esophageal squamous cell carcinoma.
Chen J; Huang ZJ; Duan YQ; Xiao XR; Jiang JQ; Zhang R
Asian Pac J Cancer Prev; 2012; 13(10):5303-6. PubMed ID: 23244153
[TBL] [Abstract][Full Text] [Related]
38. Precision of pyrosequencing assay to measure LINE-1 methylation in colon cancer, normal colonic mucosa, and peripheral blood cells.
Irahara N; Nosho K; Baba Y; Shima K; Lindeman NI; Hazra A; Schernhammer ES; Hunter DJ; Fuchs CS; Ogino S
J Mol Diagn; 2010 Mar; 12(2):177-83. PubMed ID: 20093385
[TBL] [Abstract][Full Text] [Related]
39. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
Kim JH; Bae JM; Cho NY; Kang GH
Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
[TBL] [Abstract][Full Text] [Related]
40. Small bowel adenocarcinomas in celiac disease follow the CIM-MSI pathway.
Bergmann F; Singh S; Michel S; Kahlert C; Schirmacher P; Helmke B; Von Knebel Doeberitz M; Kloor M; Bläker H
Oncol Rep; 2010 Dec; 24(6):1535-9. PubMed ID: 21042749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]